In our study, we found that blocking the expression of RACK1 greatly inhibited migration and invasion ability of glioma cells, and discovered that knockdown of RACK1 significantly decreased the expression of EMT markers, such as MMP2 and MMP9, ZEB1, N-cadherin, and Integrin-β1. Here, MMP2 is linked to central nervous system cancer.